Kreis Leslie W. (CIK 1813316) reported 37 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2025-06-30). Recent activity: Buy ACTU (71,428 shares), Buy CGTX (34,000 shares), Sell LTRN (338 shares), Sell LTRN (171 shares), Sell LTRN (10,925 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-06-30 | ACTUATE THERAPEUTICS, INC. (ACTU) | Director | Buy | 71,428 | $499,996 |
| 2025-06-20 | COGNITION THERAPEUTICS INC (CGTX) | Director | Buy | 34,000 | $0 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 338 | $1,149 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 171 | $581 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 10,925 | $36,926 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 5 | $17 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 293 | $996 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 18,678 | $63,132 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 1 | $3 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 45 | $153 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 2,886 | $9,755 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 5 | $17 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 3 | $10 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 21,557 | $72,863 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 2 | $7 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 103 | $350 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 6,601 | $22,311 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 7,206 | $22,267 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 12,319 | $38,066 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 1,903 | $5,880 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 14,218 | $43,934 |
| 2025-06-13 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 4,354 | $13,454 |
| 2025-05-29 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 3,790 | $11,560 |
| 2025-05-29 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 2,702 | $7,755 |
| 2025-05-29 | Lantern Pharma Inc. (LTRN) | 10% Owner | Sell | 3,639 | $11,026 |
Source: SEC Form 4 filings · as of 2025-06-30